Agilent/Dako

Postmeiotic Segregation Increased 2 (Autostainer Link 48)

#IR087 · western blot

14
Citing papers
239
Combined citations
Supplier page Find this product

Research areas

Genetic factors in colorectal cancer9Cancer Immunotherapy and Biomarkers3Colorectal Cancer Treatments and Studies3Colorectal Cancer Screening and Detection3Cancer Genomics and Diagnostics3Cholangiocarcinoma and Gallbladder Cancer Studies2Colorectal and Anal Carcinomas2Cancer-related Molecular Pathways1

Papers citing this product

1
Advantage of <i>HSP110</i> (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients
Oncotarget·2018·46 cit.·DOI
2
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
BMC Medicine·2024·41 cit.·DOI
3
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Modern Pathology·2018·41 cit.·DOI
4
PD‑L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study
Oncology Letters·2021·40 cit.·DOI
5
Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer
Journal of Molecular Diagnostics·2019·36 cit.·DOI
6
A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer
Biomedicines·2023·13 cit.·DOI
7
Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques
Journal of Translational Medicine·2024·6 cit.·DOI
8
Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics
Pathobiology·2022·5 cit.·DOI
9
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
Cancer Medicine·2019·4 cit.·DOI
10
Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomas
Frontiers in Oncology·2024·4 cit.·DOI